ORCHARD THERAPEUTICS PLC Assets, Fair Value Disclosure
ORCHARD THERAPEUTICS PLC had Assets, Fair Value Disclosure of $109.23 million as of 2023-09-30, per its 10-Q filed 2023-11-13.
Discontinued › Notes › Fair Value Measures and Disclosures › Fair Value Disclosures › Fair Value, Net Asset (Liability)
us-gaap:AssetsFairValueDisclosure · last filed 2023-11-13
- 2023-09-30: Assets, Fair Value Disclosure $109.23M.
- 2023-06-30: Assets, Fair Value Disclosure $124.76M.
- 2023-03-31: Assets, Fair Value Disclosure $118.53M.
- 2022-12-31: Assets, Fair Value Disclosure $102.49M.
| Period end | Assets, Fair Value Disclosure |
|---|---|
| 2023-09-30 | $109.23M 10-Q · filed 2023-11-13 |
| 2023-06-30 | $124.76M 10-Q · filed 2023-08-10 |
| 2023-03-31 | $118.53M 10-Q · filed 2023-05-15 |
| 2022-12-31 | $102.49M 10-Q · filed 2023-11-13 |
| 2022-09-30 | $111.60M 10-Q · filed 2022-11-14 |
| 2022-06-30 | $141.15M 10-Q · filed 2022-08-04 |
| 2022-03-31 | $170.87M 10-Q · filed 2022-05-12 |
| 2021-12-31 | $205.80M 10-K · filed 2023-03-14 |
| 2021-09-30 | $227.93M 10-Q · filed 2021-11-04 |
| 2021-06-30 | $237.73M 10-Q · filed 2021-08-04 |
| 2021-03-31 | $274.66M 10-Q · filed 2021-05-13 |
| 2020-12-31 | $149.46M 10-K · filed 2022-03-30 |
| 2020-09-30 | $173.79M 10-Q · filed 2020-11-03 |
| 2020-06-30 | $213.89M 10-Q · filed 2020-08-06 |
| 2020-03-31 | $256.40M 10-Q · filed 2020-05-07 |
| 2019-12-31 | $319.09M 10-K · filed 2021-03-02 |
| 2019-09-30 | $350.38M 6-K · filed 2019-11-07 |
| 2018-12-31 | $0.00 20-F · filed 2019-03-22 |
| 2017-12-31 | $0.00 20-F · filed 2019-03-22 |